ŠÛŽRܸÁÝ
¥l‹C‹LŽ–×ݷݸÞ
øê5.Œ»Ý
2018”N1ŒŽŒ»Ý¤ŠÛŽRܸÁ݂͑å‹K–͗Տ°ŽŽŒ±‚Ì’iŠK‚É“ü‚Á‚Ä‚¢‚é¡JGOGi•wl‰Èˆ««Žîᇌ¤‹†‹@\j‚ª¾ÞرV–òH‹Æ‚©‚礊ێRܸÁ݂̗LŒø«‚𒲂ׂé—Տ°ŽŽŒ±‚ðˆË—Š‚³‚ꂽ‚Ì‚Í1992”N‚¾‚Á‚½¡Žq‹{ŒzŠàIIIŠú‚ÌŠ³ŽÒ‚ð‘Ώۂɒ²‚ׂ½‚Æ‚±‚뤔Z“x‚ð40?g‚̍őå‚É‚µ‚½’ŽË‰t‚ª¤Žîᇏk¬—¦‚É—D‚ê‚Ä‚¢‚½¡‚»‚±‚Å40?g‰t‚ðŽg‚Á‚½ê‡‚ÌŠ³ŽÒ‚̐¶‘¶—¦‚ð¤“ñd–ÓŒŸŽŽŒ±‚Å’²‚ׂ邱‚Æ‚É‚È‚è¤Ìß×¾Îށi‹U–òj‚Ì‘ã‚í‚è‚Æ‚µ‚Ĥ”Z“x‚ð‹É‚ß‚Ä”–‚­‚µ‚½ŠÛŽRܸÁÝB‰ti”Z“x0.2?gj‚ðŽg‚Á‚½¡ŠÛŽRܸÁÝ40?g‰t‚Í41.5%‚ÅÌß×¾Îޑã‚í‚è‚Ì0.2?g‰tiB‰tj‚ðŽg‚Á‚½Š³ŽÒ‚Í58.2%‚Ť5”N¶‘¶—¦‚É‚¨‚¢‚Ä‚»‚̍·‚Í‹t•ûŒü‚É10%ˆÈã‚ ‚Á‚½¡
2004”N‚©‚ç‚ÍB‰t‚ð‘ΏۂƂµ‚½—Տ°ŽŽŒ±‚ðŽÀŽ{‚µ‚½¡•úŽËü—Ö@{ŠÛŽRܸÁÝB‰t‚Ƥ•úŽËü—Ö@{Ìß×¾Îނ̓ñd–ÓŒŸŽŽŒ±‚Å‚ ‚é¡‚±‚ê‚Å5”N¶‘¶—¦‚𒲂ׂ½‚Æ‚±‚뤑OŽÒ‚ª75.7%¤ŒãŽÒ‚ª65.8%‚Æ‚¢‚¤”Žš‚ªo‚½¡‚½‚¾‚µ¤—Տ°ŽŽŒ±‚ÌŠúŠÔ‚É‚¨‚¢‚Ĉã—Ë@ŠÖ‚É•úŽËü‰»Šw—Ö@‚ª“±“ü‚³‚ê‚ÄŠ³ŽÒ‚Ì—\Œã‚ª—\‘zˆÈã‚É—Ç‚­‚È‚Á‚½‚±‚Ƥ•aŠúIIŠú‚ÌŠ³ŽÒ”‚ª‘z’肵‚Ä‚¢‚½‚æ‚è‚à‘½‚©‚Á‚½‚±‚Æ‚È‚Ç‚©‚礓ŒvŠw“I‚É‚Í—LˆÓ·‚ð”F‚ß‚é‚ÉŽŠ‚ç‚È‚©‚Á‚½¡‚µ‚©‚µ¤—Տ°“I‚ɂ͈Ӗ¡‚Ì‚ ‚錋‰Ê‚Å‚ ‚Á‚½‚±‚Æ‚©‚ç[23]¤‚±‚ÌŽŽŒ±‚É‚½‚¸‚³‚í‚Á‚½é‹Êˆã‰È‘åŠw‘Ûˆã—þÝÀ°•wl‰ÈŽîᇉȋ³Žö¥“¡Œ´Œbˆê‚炪¤2013”N6ŒŽ‚ÌASCOi•Ä‘—Տ°Žîᇊw‰ïj‚É‚¨‚¢‚ĤŠÛŽRܸÁ݁iŽŽŒ±–òÜº°Äޖ¼FZ-100j‚ÌŽŽŒ±ÃÞ°À‚ð•ñ‚µ‚½[24]¡
[4]‘OÍß°¼Þ
(4.2.ˆµ‚¢‚ª¢•sŒö•½£‚¾‚Æ‚·‚é‹^˜f)
[6]ŽŸÍß°¼Þ
(6.‹r’)

23. ˜_•¶¢Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB?IVA cervical cancer with or without immunomodulator Z-100: a JGOG study£(2014)‚Ìendpoint‚ÅThe estimated total sample size was 240 to detect an 18% increase in the 5-year survival rate‚Æ‚ÌŒ‹‰Ê‚𓾂Ă¢‚é
24. Sugiyama T, Fujiwara K, Ohashi Y, Yokota H, Hatae M, Ohno T et al. (2014). gPhase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB-IVA cervical cancer with or without immunomodulator Z-100: a JGOG study.h. Ann Oncol 25 (5): 1011-7. doi:10.1093/annonc/mdu057. PMID 24569914. http://annonc.oxfordjournals.org/content/25/5/1011.abstract. 

ù~–ÚŽŸ‚É–ß‚é
o“T:Wikipedia
2018/05/28 17:30
ù¿l‹C‹LŽ–×ݷݸÞ
2018/06/23 XV
 1ˆÊª–ؓ쐰‰Ä
 2ˆÊ¨‘åã•{–k•”’nk
 3ˆÊª6ŒŽ22“ú
 4ˆÊ«Ž›“c‰®Ž–Œ
 5ˆÊ¨a’J‰·òŽ{Ý”š”­Ž–ŒÌ
£ã‚É–ß‚é
[9]WikipediaįÌß
[0]gooįÌß
¡–Ɛӎ–€
(C)NTT Resonant